Hyperpolarization-activated, cyclic nucleotide-gated (HCN) channels contribute to cationic I h current in neurons and regulate the excitability of neuronal networks. Studies in rat models have shown that the Hcn1 gene has a key role in epilepsy, but clinical evidence implicating HCN1 mutations in human epilepsy is lacking. We carried out exome sequencing for parent-offspring trios with fever-sensitive, intractable epileptic encephalopathy, leading to the discovery of two de novo missense HCN1 mutations. Screening of follow-up cohorts comprising 157 cases in total identified 4 additional amino acid substitutions. Patch-clamp recordings of I h currents in cells expressing wild-type or mutant human HCN1 channels showed that the mutations had striking but divergent effects on homomeric channels. Individuals with mutations had clinical features resembling those of Dravet syndrome with progression toward atypical absences, intellectual disability and autistic traits. These findings provide clear evidence that de novo HCN1 point mutations cause a recognizable earlyonset epileptic encephalopathy in humans.
Early infantile epileptic encephalopathies (EIEEs) are mostly sporadic disorders characterized by recurrent seizures during the neonatal or infantile periods with impaired cognitive and motor development. At least 15 different genetically determined forms of EIEE have been recognized 1, 2 . EEIEs typically result from de novo dominant mutations in a single autosomal gene, although autosomal recessive and X-linked forms also exist. Dravet syndrome, an intractable epilepsy generally occurring during the first year of life, is the prototype condition: seizures are initially febrile and prolonged, and polymorphic afebrile seizures appear later in the course of the disease. Cognitive and motor development progressively slows, progressing toward intellectual disability 3 . Dravet syndrome is mostly caused by de novo mutations of SCN1A, encoding the neuronal voltage-gated sodium α1 (Na v 1.1) channel 4, 5 . This syndrome overlaps clinically with PCDH19-related epilepsy, an X-linked disorder also associating febrile and afebrile seizures and variable degrees of intellectual disability but expressed only in heterozygous females 6, 7 .
In this study, we carried out whole-exome sequencing on 39 parent-offspring trios, including probands with EIEE resembling
De novo mutations in HCN1 cause early infantile epileptic encephalopathy Dravet syndrome without SCN1A and PCDH19 mutations. Informed consent was obtained from the families, and genetic studies were approved by local ethics committees. The analysis of exome data identified heterozygous de novo mutations (c.299C>T, p.Ser100Phe and c.1201G>C, p.Asp401His) of HCN1 (NM_021072.3) in two female probands, one French and the other Italian. We then screened 95 additional individuals with fever-sensitive EIEE (French cohort) for mutations in HCN1 coding regions by amplicon-based pyrosequencing. Three female cases were each found to have a previously unknown nonsynonymous variant (c.140G>T, p.Gly47Val; c.814T>C, p.Ser272Pro and c.890G>C, p.Arg297Thr) in a heterozygous state. The sequencing of available parental DNA showed that the mutations encoding p.Ser272Pro and p.Arg297Thr also occurred de novo. In parallel, the sequencing of several genes, including HCN1, in a Dutch follow-up cohort comprising 62 cases identified the de novo c.835C>T (p.His279Tyr) substitution in a male case. In total, six different heterozygous missense mutations, all confirmed by Sanger sequencing and absent from databases (HapMap, 1000 Genomes Project, dbSNP137 and Exome Variant Server) were identified in HCN1 (Fig. 1a) . De novo occurrence was confirmed for the five mutations for which inheritance could be investigated. The pathogenicity of the p.Gly47Val substitution remained uncertain owing to the unavailability of parental DNA.
All affected individuals had similar clinical features of seizures beginning at ages of 4 to 13 months and a combination of febrile and afebrile polymorphic seizures, including hemiclonic and generalized seizures. These features were initially suggestive of Dravet syndrome but showed different progression over time. Atypical absences, with or without myoclonic jerks, and focal seizures became predominant in the oldest subjects. All affected individuals had mild to severe intellectual disability and major behavioral disturbances, including autistic traits ( [8] [9] [10] . We recently identified a deletion spanning exon 4 of HCN1 in a female with sporadic intellectual disability and autism spectrum disorder (ASD) but no epilepsy 11 . Further analyses showed that this deletion was inherited from her asymptomatic father ( Supplementary  Fig. 2 ). As no second pathogenic mutation was found in the proband, an autosomal recessive disorder was unlikely. Intragenic HCN1 deletions alone therefore seem to be insufficient to cause intellectual disability and ASD, although they possibly contribute to these disabilities. HCN1 dysfunction may result in a spectrum of phenotypes, ranging from haploinsufficiency as an inherited risk factor for neurodevelopmental disorders to de novo mutations causing EIEE.
HCN1 is one of four genes encoding hyperpolarization-activated, cyclic nucleotide-gated channels (HCNs) with different biophysical l e t t e r s npg l e t t e r s properties expressed in the heart and brain [12] [13] [14] . In neurons, HCN1 is mainly localized to dendrites 15 . HCN subunits have six transmembrane domains, and functional channels consist of four subunits. HCN channels are permeable to sodium and potassium ions and are activated by membrane hyperpolarization. In the brain, they conduct I h current, which contributes to spontaneous rhythmic activity and the stabilization of neuronal membrane potential against excitatory or inhibitory inputs 16 . The mutations identified here affect strongly conserved amino acids, except for Gly47 and, to a lesser extent, Ser100, which are located in domains of HCN1 that are less well conserved ( Supplementary Fig. 3 and Supplementary Note).
The affected amino acids are located in different parts of the channel, but all are intracellular, and four are located close to domains forming the channel pore (Fig. 1b) , in particular in the S4-S5 linker involved in voltage-dependent gating 14 .
We assessed the functional consequences of the de novo mutations identified in EIEE cases by carrying out patch-clamp recordings on Chinese hamster ovary (CHO-K1) cells expressing wild-type or mutant human HCN1 channels. Voltage-dependent, slowly activating inward currents were recorded in cells expressing wild-type, Ser100Phe, His279Tyr and Asp401His HCN1 proteins, consistent with the expression of functional channels (Fig. 2a,b) . The three mutants had major effects on channel gating (Fig. 2c) . Half-activation voltage (V 1/2 ) for the Ser100Phe and His279Tyr channels was depolarized by ~27 mV and ~17 mV, respectively, compared to wild-type HCN1. Asp401His HCN1 was activated at higher positive voltages owing to a 46-mV shift in the activation curve. The Ser100Phe and Asp401His mutants also resulted in significantly faster activation than wild-type HCN1 (Fig. 2d) . Furthermore, all three mutants showed slower deactivation than the wild-type channel (Fig. 2e) . Finally, the Ser100Phe mutant also significantly shifted the reversal potential to negative voltage (P < 0.001; Supplementary Fig. 4) . Together, these results indicate that Ser100Phe, His279Tyr and Asp401His lead to a gain of function for homotetrameric HCN1 channels. By contrast, no I h current was recorded for cells expressing the Ser272Pro and Arg297Thr channels ( Fig. 2a and Supplementary Fig. 5 ). These mutant channels were present in lower amounts in cell lysates and at the plasma membrane compared to wild-type channel, but similarly reduced protein WT (21) S100F (9) H279Y (12) D401H (14) WT (18) S100F (6) H279Y ( and Ser100Phe mutant channels have higher activation time constants than wild-type human HCN1 channel (one-way ANOVA, ***P < 0.001).
(e) The three mutant channels display enhanced deactivation time constants compared with those of wild-type human HCN1 (one-way ANOVA, *P < 0.05, ***P < 0.001). Data are presented as means ± s.e.m. with the numbers of experiments indicated in parentheses.
npg l e t t e r s expression, probably due to the instability of the mutated proteins, was also observed for other mutants retaining substantial channel activity, such as Ser100Phe (Supplementary Fig. 6 ), indicating that loss of function was specific to these amino acid changes.
To gain further insights into the mechanisms by which mutations with apparently divergent effects cause similar phenotypes and to mimic the heterozygous state of the mutations in the cases, we performed coexpression of wild-type and mutant HCN1 proteins. Strikingly, Arg297Thr and, to a lesser extent, Ser100Phe and Ser272Pro HCN1 but not Asp401His had a dominant-negative effect on the wild-type form, decreasing the current density of heteromeric channels (Fig. 3) . These results support the hypothesis that the de novo HCN1 mutations identified in this study mostly lead to gain-offunction or dominant-negative effects rather than loss of function.
I h current regulates neuronal excitability and the dendritic integration of synaptic potentials in individual neurons and neuronal networks 13, 14, 17, 18 . HCN1 and HCN2 are the main HCN isoforms expressed in the brain and contributing to this current. HCN1 is predominantly expressed in the neocortex and hippocampus, whereas HCN2 is expressed more evenly but shows slightly stronger expression in the thalamus than elsewhere 19, 20 . Acquired I h current dysfunction, due to abnormal Hcn1 expression or distribution in particular, has been shown to have a crucial role in epileptogenic processes in rats 14, 16, 21, 22 . HCN1 defects were thus predicted to contribute to epilepsy in humans as well, and HCN1 was screened for mutations in persons with idiopathic generalized epilepsy (IGE) 23, 24 . Our results finally provide the first evidence, to our knowledge, implicating HCN1 mutations in human epilepsy and show that the associated phenotype is more severe than in the individuals with IGE who were previously screened.
Functional studies confirmed that the de novo mutations had major effects on HCN1 function and mostly led to gain of function. However, the precise mechanisms by which mutations cause EIEE in humans remain to be clarified. The observations for loss-of-function mutations were consistent with previous findings describing a decrease in Hcn1 expression occurring very early in epileptogenesis in seizureinduced or spontaneous epileptic rat models [25] [26] [27] [28] [29] and an upregulation of HCN channel function by some antiepileptic drugs 30, 31 . However, rare heterozygous deletions encompassing HCN1 exons exist in nonepileptic individuals, and Hcn1-null mice have motor learning and memory deficits 32 and higher susceptibility to induced seizures 33, 34 but display no spontaneous seizures 32 . These observations suggest that HCN1 haploinsufficiency, in contrast to point mutations altering channel function, can be functionally tolerated by the developing brain and that HCN1 deficiency promotes neuronal excitability but is insufficient for seizure development. HCN1 proteins with amino acid substitutions are predicted to be present in the cells of affected individuals, with the HCN subunits assembling into functional homo-or heterotetramers 13 . Thus, missense mutations may have dominant-negative effects, interfering with the function of the remaining HCN1 allele, as demonstrated for the Arg297Thr and Ser272Pro mutants, but also with the function of HCN2 in neurons in which these channels are both expressed. Consistent with this hypothesis, Hcn2-null mice display spontaneous absence seizures 35, 36 , and a recessive loss-of-function mutation in HCN2 was recently identified in one person with IGE 37 . Alternatively, both increases and decreases in I h current may be pathogenic, as both the downregulation and upregulation of Hcn1 expression have been reported, depending on the epileptic rat model 13, 22 . Finally, HCN1 mutations may have opposite (loss-of-function or gain-of-function) effects depending on the physiological context and cells in which they are expressed, as observed for Na v 1.1 and Na v 1.7 channels 38, 39 .
In conclusion, this study provides further evidence of the crucial role of HCN1 and I h current in human epilepsies. The phenotype 
